%A Zhou,Zilong %A Cong,Lele %A Cong,Xianling %D 2021 %J Frontiers in Oncology %C %F %G English %K Organoids,Patient-derived organoid,Living biobanks,Microfluidics,drug screening,Organoids-on-a-chip %Q %R 10.3389/fonc.2021.762184 %W %L %M %P %7 %8 2021-December-30 %9 Review %+ Lele Cong,Department of Dermatology, China-Japan Union Hospital of Jilin University,China,congxl@jlu.edu.cn %+ Xianling Cong,Department of Dermatology, China-Japan Union Hospital of Jilin University,China,congxl@jlu.edu.cn %# %! Patient-Derived Organoids in Precision Medicine %* %< %T Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank %U https://www.frontiersin.org/articles/10.3389/fonc.2021.762184 %V 11 %0 JOURNAL ARTICLE %@ 2234-943X %X Organoids are in vitro self-assembling, organ-like, three-dimensional cellular structures that stably retain key characteristics of the respective organs. Organoids can be generated from healthy or pathological tissues derived from patients. Cancer organoid culture platforms have several advantages, including conservation of the cellular composition that captures the heterogeneity and pharmacotypic signatures of the parental tumor. This platform has provided new opportunities to fill the gap between cancer research and clinical outcomes. Clinical trials have been performed using patient-derived organoids (PDO) as a tool for personalized medical decisions to predict patients’ responses to therapeutic regimens and potentially improve treatment outcomes. Living organoid biobanks encompassing several cancer types have been established, providing a representative collection of well-characterized models that will facilitate drug development. In this review, we highlight recent developments in the generation of organoid cultures and PDO biobanks, in preclinical drug discovery, and methods to design a functional organoid-on-a-chip combined with microfluidic. In addition, we discuss the advantages as well as limitations of human organoids in patient-specific therapy and highlight possible future directions.